Basel, 02 July 2018 Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Foundation Medicine, Inc. (NASDAQ: FMI) at a... Read more
Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market SANTA CLARA, Calif.–(BUSINESS WIRE)–Jun. 28, 2018– Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme,... Read more
Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market SANTA CLARA, Calif.–(BUSINESS WIRE)–Jun. 28, 2018– Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme,... Read more
Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market SANTA CLARA, Calif.–(BUSINESS WIRE)–Jun. 28, 2018– Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held ProZyme,... Read more
Thermo Fisher Scientific Signs Agreement to Acquire Gatan from Roper Technologies WALTHAM, Mass. and SARASOTA, Fla., June 28, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Roper Technologies, Inc. (NYSE: ROP), a leading diversified technology company, today announced that they have entered into a definitive agreement under which... Read more
WALTHAM, Mass. and SARASOTA, Fla., June 28, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Roper Technologies, Inc. (NYSE: ROP), a leading diversified technology company, today announced that they have entered into a definitive agreement under which Thermo Fisher will acquire Gatan, Inc., a wholly owned subsidiary of... Read more
Agilent Technologies to Expand Biopharma Consumables Portfolio with Acquisition of ProZyme SANTA CLARA, Calif., June 28, 2018 Highlights: Highly synergistic with Agilent’s current customer-base and sales channel Enables complete LC and LC/MS workflow solutions in important glycan biopharma segment Strengthens Agilent’s customer value proposition in fast-growing biopharma market Agilent Technologies, Inc. (NYSE: A) today announced that... Read more
Zipf, Austria – June 28, 2018 – In the lead up to the European Society of Human Reproduction and Embryology (ESHRE) annual conference, GE Healthcare and Vitrolife are partnering to improve patient outcomes in assisted reproductive medicine. Infertility is a growing health issue that affects a significant number of women and couples around the world.... Read more
Shimadzu Corporation (hereinafter “Shimadzu”) has signed an agreement to acquire all shares of infraserv Vakuumservice GmbH (hereinafter “IVG”), which is involved in servicing turbomolecular pumps in Europe. After completion of the required acquisition process, IVG will be our wholly owned subsidiary in July. Background and Purpose of Acquisition In the semiconductor market expected to further... Read more
Download as PDF JUNE 25, 2018 MINNEAPOLIS and WALTHAM, Mass., June 25, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today that it has reached agreement to acquire Exosome Diagnostics, Inc. for $250 million in cash plus contingent consideration of up to $325 million due upon the achievement of certain future milestones. The transaction is expected... Read more